New Noninvasive Device for Hand Tremor Relief
Adults with Parkinson disease or essential tremor now have a new option for temporary relief via adaptive stimulation.
Updated on Oct. 30, 2026 in Alzheimer’s
Live Poll
Would you prefer noninvasive wearable devices over traditional medication or surgery for treating chronic conditions?
Cala Health released the Cala kIQ Plus System nationwide on October 6, 2026, to provide temporary hand tremor relief. The device offers a noninvasive management option for adults living with Parkinson disease or essential tremor.
Why it matters
For patients seeking to manage tremors without medication or brain surgery, this device offers a new noninvasive therapeutic tool. It allows users to adjust their treatment approach daily to better address fluctuations in tremor severity.
A clinical assessment presented in April 2026 found that 76% to 89% of patients achieved at least a 1-point reduction on the TETREAS performance score using three distinct stimulation modes. The findings remain preliminary regarding long-term outcomes compared to existing care standards.
The players
Cala Health
A medical technology company focused on developing wearable neuromodulation therapies for chronic neurological conditions.
The details
The device uses transcutaneous afferent patterned stimulation to target nerves involved in tremor control. Users can select from three stimulation waveform modes and modify them as needed, while the system performs adaptive calibration before every session to account for daily shifts in tremor activity. This personalized calibration aims to optimize the therapeutic signal delivered to the patient.
Timeline
Clinical findings were presented at the AAN Annual Meeting in April 2026.
Cala Health announced the nationwide availability of the device on October 6, 2026.
Health Landscape
This launch reflects a broader shift toward wearable neuromodulation as an alternative to invasive interventions for movement disorders. It builds upon clinical data presented at the American Academy of Neurology Annual Meeting to address patient needs for non-pharmacological tremor control.
If you are managing tremors, this device may be a topic to discuss with your neurologist to see if noninvasive stimulation is appropriate for your specific tremor pattern. It is worth evaluating whether your current daily care plan meets your relief needs.
The takeaway
The Cala kIQ Plus System provides a new option for managing tremors through daily adaptive stimulation. Patients interested in noninvasive alternatives to surgery or medication should consult their physician about current management options for essential tremor or Parkinson disease.
Further reading
For more on managing neurological conditions, visit Alzheimer’s.
Source note: This article includes information reported by Neurology Advisor.
Live Poll
Would you prefer noninvasive wearable devices over traditional medication or surgery for treating chronic conditions?
